284 related articles for article (PubMed ID: 31548244)
1. Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial.
Jakubowicz D; Landau Z; Tsameret S; Wainstein J; Raz I; Ahren B; Chapnik N; Barnea M; Ganz T; Menaged M; Mor N; Bar-Dayan Y; Froy O
Diabetes Care; 2019 Dec; 42(12):2171-2180. PubMed ID: 31548244
[TBL] [Abstract][Full Text] [Related]
2. Serum from type 2 diabetes patients consuming a three-meal diet resets circadian rhythms in cultured hepatocytes.
Tsameret S; Jakubowicz D; Landau Z; Wainstein J; Ganz T; Raz I; Chapnik N; Froy O
Diabetes Res Clin Pract; 2021 Aug; 178():108941. PubMed ID: 34245798
[TBL] [Abstract][Full Text] [Related]
3. Role of High Energy Breakfast "Big Breakfast Diet" in Clock Gene Regulation of Postprandial Hyperglycemia and Weight Loss in Type 2 Diabetes.
Jakubowicz D; Wainstein J; Tsameret S; Landau Z
Nutrients; 2021 May; 13(5):. PubMed ID: 34063109
[TBL] [Abstract][Full Text] [Related]
4. Individualized Meal Replacement Therapy Improves Clinically Relevant Long-Term Glycemic Control in Poorly Controlled Type 2 Diabetes Patients.
Kempf K; Röhling M; Niedermeier K; Gärtner B; Martin S
Nutrients; 2018 Aug; 10(8):. PubMed ID: 30081574
[No Abstract] [Full Text] [Related]
5. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
6. Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial.
Jakubowicz D; Wainstein J; Landau Z; Raz I; Ahren B; Chapnik N; Ganz T; Menaged M; Barnea M; Bar-Dayan Y; Froy O
Diabetes Care; 2017 Nov; 40(11):1573-1579. PubMed ID: 28830875
[TBL] [Abstract][Full Text] [Related]
7. Response to intensive therapy steps and to glipizide dose in combination with insulin in type 2 diabetes. VA feasibility study on glycemic control and complications (VA CSDM).
Abraira C; Henderson WG; Colwell JA; Nuttall FQ; Comstock JP; Emanuele NV; Levin SR; Sawin CT; Silbert CK
Diabetes Care; 1998 Apr; 21(4):574-9. PubMed ID: 9571345
[TBL] [Abstract][Full Text] [Related]
8. Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study.
Akturk HK; Snell-Bergeon JK; Rewers A; Klaff LJ; Bode BW; Peters AL; Bailey TS; Garg SK
Diabetes Technol Ther; 2018 Oct; 20(10):639-647. PubMed ID: 30207748
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Low-Carbohydrate Diet on Glycemic Control in Patients with Type 2 Diabetes Mellitus.
Wang LL; Wang Q; Hong Y; Ojo O; Jiang Q; Hou YY; Huang YH; Wang XH
Nutrients; 2018 May; 10(6):. PubMed ID: 29882884
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial).
Lind M; Hirsch IB; Tuomilehto J; Dahlqvist S; Ahrén B; Torffvit O; Attvall S; Ekelund M; Filipsson K; Tengmark BO; Sjöberg S; Pehrsson NG
BMJ; 2015 Oct; 351():h5364. PubMed ID: 26512041
[TBL] [Abstract][Full Text] [Related]
11. Clinical Application of the Food Insulin Index for Mealtime Insulin Dosing in Adults with Type 1 Diabetes: A Randomized Controlled Trial.
Bell KJ; Gray R; Munns D; Petocz P; Steil G; Howard G; Colagiuri S; Brand-Miller JC
Diabetes Technol Ther; 2016 Apr; 18(4):218-25. PubMed ID: 26840067
[TBL] [Abstract][Full Text] [Related]
12. High-energy breakfast based on whey protein reduces body weight, postprandial glycemia and HbA
Jakubowicz D; Wainstein J; Landau Z; Ahren B; Barnea M; Bar-Dayan Y; Froy O
J Nutr Biochem; 2017 Nov; 49():1-7. PubMed ID: 28863364
[TBL] [Abstract][Full Text] [Related]
13. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
[TBL] [Abstract][Full Text] [Related]
14. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
15. Effect of carbohydrate restriction in the first meal after an overnight fast on glycemic control in people with type 2 diabetes: a randomized trial.
Pedersen E; Lange K; Clifton P
Am J Clin Nutr; 2016 Nov; 104(5):1285-1291. PubMed ID: 27733405
[TBL] [Abstract][Full Text] [Related]
16. Comment on Jakubowicz et al. Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial. Diabetes Care 2019;42:2171-2180.
Saraiva IE
Diabetes Care; 2020 Jan; 43(1):e12. PubMed ID: 31862828
[No Abstract] [Full Text] [Related]
17. Response to Comment on Jakubowicz et al. Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial. Diabetes Care 2019;42:2171-2180.
Froy O
Diabetes Care; 2020 Jan; 43(1):e13-e14. PubMed ID: 31862829
[No Abstract] [Full Text] [Related]
18. Meal replacement reduces insulin requirement, HbA1c and weight long-term in type 2 diabetes patients with >100 U insulin per day.
Kempf K; Schloot NC; Gärtner B; Keil R; Schadewaldt P; Martin S
J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():21-7. PubMed ID: 23909831
[TBL] [Abstract][Full Text] [Related]
19. Effects on post-prandial glucose and AGE precursors from two initial insulin strategies in patients with type 2 diabetes uncontrolled by oral agents.
Sakharova OV; Lleva RR; Dziura JD; Spollett GR; Howell SK; Beisswenger PJ; Inzucchi SE
J Diabetes Complications; 2012; 26(4):333-8. PubMed ID: 22541894
[TBL] [Abstract][Full Text] [Related]
20. Insulin requirement profiles and related factors of insulin pump therapy in patients with type 2 diabetes.
Yang X; Deng H; Zhang X; Yang D; Yan J; Yao B; Weng J; Xu W
Sci China Life Sci; 2019 Nov; 62(11):1506-1513. PubMed ID: 31197759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
